You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨貝康醫療漲近8%,與Rhea Labs訂立戰略合作協議
格隆匯 02-26 11:01
貝康醫療(2170.HK)盤中漲近8%,報3.63港元,股價創2024年11月7日以來新高。消息面上,公司公佈,與瑞雅集團全資子公司Rhea Labs訂立戰略合作協議,爲期五年。據此,公司將向Rhea Labs提供高品質醫療產品及綜合解決方案,支持Rhea Labs生殖機構建設;雙方將在美國、歐洲、東南亞等地區共同推動品牌化建設;及基於人工智能技術合作開發新產品。貝康醫療董事會認爲,戰略合作協議將使集團能夠幫助公司拓展銷售渠道並加強其在輔助生殖技術市場的地位,符合公司及其股東的整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account